NVEC INVESTIGATION: NVE Corp. Investors Should Contact Block & Leviton to Possibly Recover Losses
Key Highlights
- ➤Q2 fiscal 2027 revenue fell 47% from the prior quarter
- ➤Product sales dropped 48%; defense product sales decreased 95%
- ➤Diluted EPS declined 51% quarter over quarter
- ➤NVE shares fell as much as $31.56, or 30.6%, intraday
- ➤Block & Leviton investigates potential securities law violations
Expert Statements
NVE Corporation Principal Financial Officer, Principal Financial Officer of NVE Corporation
“a short-term inventory adjustment at one of its large medical device customers and a 95% decrease in defense product sales”
NVE Corporation CEO, CEO of NVE Corporation
“the swing came mainly from orders being pulled into the first quarter from the second”
BOSTON, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Block & Leviton is investigating NVE Corporation (Nasdaq: NVEC) for potential securities law violations. Investors who have lost money in their NVE investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/nvec.
Block & Leviton is investigating whether NVE Corporation or its executives misled investors about the company's financial performance and business outlook, including demand from key customers and the timing of orders. On October 21, 2026, NVE reported second-quarter fiscal 2027 results showing that, compared to the prior quarter, revenue fell 47%, product sales fell 48%, gross profit fell 49%, and diluted earnings per share fell 51%. On the earnings call, the company's Principal Financial Officer attributed the drop in product sales to a short-term inventory adjustment at one of its large medical device customers and a 95% decrease in defense product sales. The CEO added that the swing came mainly from orders being pulled into the first quarter from the second. Following this news, NVE's stock fell as much as $31.56 per share, or about 30.6%, in intraday trading on October 22, 2026.
Get started
Create a free account to read the full story.
